AI and aerospace "dual engines" accelerate! Goldman Sachs sets SpaceX (SPCX.US) target price at $230
智通财经2026/10/06 07:06According to Odaily, it is reported that ahead of SpaceX (SPCX.US) announcing its financial results for the third quarter of 2026 on November 5th Eastern Time, Goldman Sachs recently released a research report updating and raising its forecasts for the company’s artificial intelligence (AI) business. This update is based on the company's recent business activities, latest public statements, key enterprise use cases, and progress in model development, including projections for computing power capacity, revenue, and profit margins. As the company continues to demonstrate high levels of operational execution, Goldman Sachs will further analyze potential monetization scenarios for computing power from the 2026 to 2028 fiscal years. The report notes that, in the absence of a broader correction in the AI operating environment, predictions for the company’s AI business over the next 6 to 18 months remain relatively conservative compared to the market consensus. Additionally, regarding the aerospace business, Goldman Sachs discussed recent related news and considered how ongoing increases in launch frequency and reusability in the coming years could impact the company's long-term growth opportunities.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Day-ahead base load electricity prices in Germany and France fell, with a slight difference in the decline.
(1) Germany's OTC next-day baseload power price dropped by around 10%, falling to approximately 189 euros per megawatt-hour. (2) France's OTC next-day baseload power price fell by about 7%, dropping to around 186 euros per megawatt-hour. (3) The simultaneous decrease in electricity prices in both countries reflects a loosening of the short-term power supply and demand situation. (4) Germany's larger decline compared to France may be related to changes in wind power output or demand-side factors. (5) Going forward, attention should be paid to the impact of weather, renewable energy generation, and fuel costs on electricity prices.
French industrial data cools, fiscal risks disturb the bond market
(1) France's industrial production data for August showed a decline, with reduced electricity demand offsetting moderate growth in the manufacturing sector. (2) Specifically, industrial output in August fell by about 0.3% month-on-month, while July had reached its highest level since 2021. (3) Economists had widely expected a slight positive growth for August, but the actual result was clearly below expectations. (4) Manufacturing output grew about 0.3% month-on-month but was offset by a decrease in electricity production, resulting in overall weaker industrial performance. (5) This data reflects that the eurozone’s second-largest economy still faces significant challenges in driving growth. (6) France barely avoided recession in the first half of this year and now faces new economic headwinds. (7) There is growing market concern over whether the minority government can control the widening fiscal deficit. (8) The dual challenges of economic and fiscal pressures have increased sell-off stress in the bond market. (9) France’s relative borrowing costs have risen to their highest levels since the eurozone debt crisis compared to other countries. (10) Comments by Trump regarding tariffs have also raised market concerns and further dampened risk appetite. (11) Attention should be paid to the future direction of France’s fiscal policy and changes in the bond market climate to assess whether industrial and overall economic stability can be achieved.
Von der Leyen says the EU must address dependence on foreign fossil fuel markets
President of the European Commission Ursula von der Leyen: We must address the structural issues that expose us to the volatility of foreign fossil fuel markets.
Genmab shares rise 8% as AbbVie’s combination therapy confirms reduced risk of death
Genmab shares rose by 8% after its blood cancer drug combination, developed in collaboration with AbbVie, was shown to reduce the risk of death.
Crypto prices
More
